Table 1Percent remaining of ML308 at the conclusion of the experiment (8h)
- Review ML365: Development of Bis-Amides as Selective Inhibitors of the KCNK3/TASK1 Two Pore Potassium Channel.[Probe Reports from the NIH Mol...]Review ML365: Development of Bis-Amides as Selective Inhibitors of the KCNK3/TASK1 Two Pore Potassium Channel.Zou B, Flaherty DP, Simpson DS, Maki BE, Miller MR, Shi J, Wu M, McManus OB, Golden JE, Aubé J, et al. Probe Reports from the NIH Molecular Libraries Program. 2010
- Review Identification of a novel, small molecule inhibitor of KCNQ2 channels.[Probe Reports from the NIH Mol...]Review Identification of a novel, small molecule inhibitor of KCNQ2 channels.Yu H, Xu K, Zou B, Wu M, McManus OB, Le Engers J, Cheung YY, Salovich JM, Hopkins CR, Lindsley CW, et al. Probe Reports from the NIH Molecular Libraries Program. 2010
- Review Identification of a novel, small molecule activator of KCNQ1 channels.[Probe Reports from the NIH Mol...]Review Identification of a novel, small molecule activator of KCNQ1 channels.Yu H, Lin Z, Xu K, Huang X, Long S, Wu M, McManus OB, Le Engers J, Mattmann ME, Engers DW, et al. Probe Reports from the NIH Molecular Libraries Program. 2010
- Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3.[Biochem Biophys Res Commun. 2017]Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3.Wright PD, Veale EL, McCoull D, Tickle DC, Large JM, Ococks E, Gothard G, Kettleborough C, Mathie A, Jerman J. Biochem Biophys Res Commun. 2017 Nov 4; 493(1):444-450. Epub 2017 Sep 5.
- A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.[Assay Drug Dev Technol. 2010]A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.Schmalhofer WA, Swensen AM, Thomas BS, Felix JP, Haedo RJ, Solly K, Kiss L, Kaczorowski GJ, Garcia ML. Assay Drug Dev Technol. 2010 Dec; 8(6):714-26.
- Table 1, Percent remaining of ML308 at the conclusion of the experiment (8h) - P...Table 1, Percent remaining of ML308 at the conclusion of the experiment (8h) - Probe Reports from the NIH Molecular Libraries Program
- Homo sapiens fatty acid amide hydrolase 2 (FAAH2), mRNAHomo sapiens fatty acid amide hydrolase 2 (FAAH2), mRNAgi|30410024|ref|NM_174912.2|Nucleotide
- RecName: Full=Dynein light chain 1, cytoplasmic; AltName: Full=8 kDa dynein ligh...RecName: Full=Dynein light chain 1, cytoplasmic; AltName: Full=8 kDa dynein light chain; Short=DLC8; AltName: Full=Dynein light chain LC8-type 1; AltName: Full=Protein inhibitor of neuronal nitric oxide synthase; Short=PIN; Short=mPINgi|52783579|sp|P63168.1|DYL1_MOUSEProtein
- Homo sapiens clone 24803 mRNA sequenceHomo sapiens clone 24803 mRNA sequencegi|3283895|gb|AF070628.1|AF070628Nucleotide
- Chain A, Neurexin-1-alphaChain A, Neurexin-1-alphagi|340707968|pdb|3R05|AProtein
Your browsing activity is empty.
Activity recording is turned off.
See more...